T A B L E O F C O N T E N
Updated evidence is of low quality, and potential differences between early and late tracheostomy need to be better investigated by means of randomized controlled trials. At present there is no specific information about any subgroup or individual characteristics potentially associated with better outcomes with either early or late tracheostomy.
P L A I N L A N G U A G E S U M M A R Y

Timing of tracheostomy for critically ill patients who are predicted to be on long-term artificial respiration
Tracheostomy is a surgical procedure where an external artificial opening is made in the trachea (windpipe). Long-term mechanical ventilation (where a machine is used to mechanically assist breathing) is the most common situation where tracheostomy is indicated for patients in intensive care units (ICU). 'Early' and 'late' tracheostomies may be undertaken, categorised by the timing of tracheostomy. We included four studies in this systematic review, with a total of 673 patients randomized to either an early or late tracheostomy. There was no significant difference between early and late tracheostomies for patient deaths (mortality). The more significant effects of early tracheostomy were the reduction in time spent on ventilatory support (by around nine days) and in the intensive unit care (by around 11 days), but even so the results were limited because they were observed in individual studies that had a high risk of bias (systematic error) and a relatively low number of patients. There was no significant difference between the comparison groups with regards to undesired events such as tracheal stenosis (narrowing of the trachea or windpipe) in hospital and sepsis (blood infection) because of respiratory infection. Possible differences between early and late tracheostomy still need to be adequately investigated by means of further randomized controlled trials. Moreover, there is no information about the best indication for either early or late tracheostomy in patients with specific characteristics. The mean time spent on mechanical ventilation in the intervention groups was 9.8 lower (8.12 to 11.48 lower) 8
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B A C K G R O U N D Description of the condition
Long-term mechanical ventilation is the most common situation where tracheostomy is indicated for patients in intensive care units (ICU) (Heffner 2001) . Although the definition of prolonged ventilation can include periods as short as 24 hours (Criner 1994; Griffiths 2005) , only patients who are foreseen to be on artificial ventilation for around 10 days or more (Armstrong 1998; Plummer 1989) are generally subjected to elective tracheostomy. In this circumstance, tracheostomy is offered as a strategy to reduce respiratory injury and other undesired consequences of prolonged translaryngeal intubation. These include ventilator-associated pneumonia (Ranes 2006) , sinusitis (Holzapfel 1993) and tracheal stenosis (Cavaliere 2007) . Some predictive systems have been used to predict the duration of mechanical ventilation in various patient settings (Agle 2006; Gajic 2007; Légaré 2001; Sellers 1997) but many of these systems are not appropriately validated. Several other factors have also been shown to provide indications for tracheostomy: neuromuscular disease or trauma, age, injury severity score, damage control laparotomy, and others (Frutos-Vivar 2005; Goettler 2006 ). Other researchers propose that the decision to perform tracheostomy should be based on objective measures from spontaneous breathing trials or weaning from mechanical ventilation trials (Freeman 2008) . Thus, the development of predictive methods tailored for each clinical condition would be a major advance in patient care.
Description of the intervention
Tracheostomy is a surgical procedure where an external, artificial opening is made in the trachea (Stedman 1995) . A number of techniques are used to perform tracheostomy. The main ones are the classical standard surgical procedure (in a surgical room) and the percutaneous method performed at the patient's bedside (Friedman 2006; Gullo 2007; Pappas 2011; Schultz 2007) . The surgical and percutaneous procedures are usually performed by different surgical specialists such as general, thoracic, ear, nose and throat (ENT) or maxillofacial surgeons, while the percutaneous procedures are usually but not exclusively performed by surgeons and intensivists (Pappas 2011; Plummer 1989) . There is also a diversity of materials (equipment and designs) used in performing tracheostomy (Björling 2007; Crimlisk 2006; Hess 2005) . These can potentially be associated with complications such as tracheal ulceration, distortion of soft tracheal tissue and airway obstruction (Tibballs 2006) . Plummer 1989 used the translaryngeal route for patients expected to be on mechanical ventilation for up to 10 days and tracheostomy for those on artificial ventilation for longer than 21 days; however, tracheostomy is usually performed between the 10th and 14th day of intubation (Armstrong 1998 
How the intervention might work
Potential benefits from tracheostomy include: lower airway resistance, easier and safer tracheal suction, greater patient comfort, better communication, oral feeding, faster weaning from the ventilator and lower rates of ventilator-associated pneumonia (Heffner 2001; Plummer 1989) . On the other hand, some of the disadvantages of tracheostomy include: dislodgement or obstruction, wound infection, scarring, a false passage, haemorrhage and subglottic and tracheal stenosis (Bartels 1998; Dollner 2002; Higgins 2007; Norwood 2000) .
Why it is important to do this review
The present review intended to systematically map the evidence on timing of tracheostomy (early versus late) in mechanically ventilated, critically ill patients.
O B J E C T I V E S
To evaluate the effectiveness and safety of early (≤ 10 days after tracheal intubation) versus late tracheostomy (> 10 days after tracheal intubation) in critically ill adult patients predicted to be on prolonged mechanical ventilation and with different clinical conditions.
Types of studies
We included all randomized or quasi-randomized controlled trials (RCTs) published in any language. We included studies published in abstract form if sufficient information regarding their methods and results were provided. We approached the principal authors for additional information wherever necessary.
Types of participants
Inclusion criteria
• Critically ill patients (for whom death is possible or imminent)
• Patients expected to be on prolonged mechanical ventilation • Adults (≥ 18 years)
We defined prolonged mechanical ventilation as ventilation for from 24 hours to 21 consecutive days, six or more hours per day (Divo 2010; Shirzad 2010).
Exclusion criteria
• Anatomical anomalies of the neck which would impair the tracheostomy procedure
• Patients already tracheostomized • Coagulation disturbances (e.g., thrombocytopenia)
• Soft tissue infection of neck
Types of interventions
We considered the following comparison arms. 1. Early tracheostomy, if no serious attempt was made to wean the patients from the ventilator (tracheostomy based only on clinical or laboratory results, performed from two days to 10 days after intubation).
2. Late tracheostomy, where weaning had not been successful, performed later than 10 days after intubation.
Types of outcome measures
We considered all outcomes measures found in the primary studies. For each outcome we accepted the definition used by the study authors. We discussed, where necessary, limitations such as the use of non-validated instruments for evaluation or a divergence of definitions.
Primary outcomes
1. Mortality (time to mortality or frequency of deaths at any time point: in hospital, in ICU, or after discharge) 2. Duration of artificial ventilation CIN-HAL (1982 to December 2010 . The search strategy for MEDLINE included terms for clinical condition and intervention as well as their synonyms (see Appendix 2). This strategy was modified as required for other databases (see Appendix 3 (CENTRAL); Appendix 4 (EMBASE); Appendix 5 (LILACS); Appendix 6 (Current Controlled trials) Appendix 7 (PEDro); and Appendix 8 (CINAHL). We used a highly sensitive search filter for randomized controlled trials in databases where it was necessary (MEDLINE, EMBASE and LILACS) to optimize the search process (Higgins 2011b). We did not impose any language restriction.
Searching other resources
We handsearched the references of relevant articles including narrative reviews and non-randomized controlled studies in the area of mechanical ventilation. We searched for ongoing randomized controlled trials in the Current Controlled Trials database at http://www.controlledtrials.com/.
Data collection and analysis
Selection of studies
Two authors (HS and BGS) independently analysed the titles and abstracts of publications obtained by the search strategy. We (RA and BGS) acquired all studies that met our inclusion criteria as full text.
Data extraction and management
We (RA and BGS) extracted data using a specially designed data extraction sheet (Appendix 9) containing information about methods (study design), participants, interventions (for example surgical procedures, materials) and results. We resolved all disagreements by consensus. We contacted the authors of the primary studies for further information about methodology and participants, when necessary. Two authors (RA and BGS) abstracted the data and entered all data into Review Manager (RevMan 5.1). A third author (HS) rechecked all entries.
Assessment of risk of bias in included studies
Two authors (RA and BGS) assessed all included studies for methodological quality based on the criteria described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011a).
1. Was the random allocation sequence adequately generated? 2. Was allocation adequately concealed? 3. Was knowledge of the allocated interventions adequately prevented for data collectors, or they were independent from the researchers who planned the study (blinding)?
4. Were incomplete outcome data adequately addressed? 5. Are reports of the study free of suggestion of selective reporting?
6. Was the study apparently free of other bias? We classified each of the items as low risk of bias, high risk of bias or unclear risk of bias. Because of the nature of the interventions of interest for this systematic review, we considered item 3 (blinding) only at the data collection level.
Measures of treatment effect
For comparable studies, dichotomous data were expressed as relative risk (RR) with 95% confidence intervals (CI) using the random-effects model (Deeks 2001a). We calculated number needed to treat (NNT) where risk differences were statistically significant (Christensen 2006) . For continuous data we calculated the mean difference using the random-effects model. We planned to calculate the standardized mean difference when the trials assessed the same outcome but used different instruments or scales (Deeks 2001b) .
Unit of analysis issues
We based the unit of analysis on the individual patient (unit to be randomized for interventions to be compared) (Higgins 2011a). We did not expect to find cross-over study designs because of the characteristics of the intervention.
Dealing with missing data
Irrespective of the type of data, we planned to report dropout rates in the table Characteristics of included studies and perform intention-to-treat (ITT) analysis only for dichotomous data (Deeks 2005).
Assessment of heterogeneity
We presented data using a random-effects model (DerSimonian 1986) . We quantified inconsistency among the pooled estimates using the Chi 2 statistic, for heterogeneity we used the I 2 statistic (where I 2 = [(Q -df )/Q] x 100%; Q is the Chi 2 statistic and df its degrees of freedom) . This illustrates the percentage of the variability in effect estimates resulting from heterogeneity rather than from sampling error (Higgins 2002; Higgins 2003) . We decided not to combine the studies in a meta-analysis when they presented substantial clinical and methodological heterogeneity in conjunction with statistical heterogeneity as indicated by the I 2 statistic, according to the following thresholds:
• 0% to 40%: may not be important;
• 30% to 60%: may represent moderate heterogeneity;
• 50% to 90%: may represent substantial heterogeneity;
• 75% to 100%: considerable heterogeneity.
Assessment of reporting biases
We planned to assess publication bias or a systematic difference between the smaller and larger studies (small study effects) by preparing a funnel plot (trial effect versus trial size) if a sufficient number of studies were available (Copas 2000).
Data synthesis
We synthesized qualitative information relative to methods, risk of bias, description of participants and outcomes measures and presented them in the table 'Characteristics of included studies'. For quantitative data, we planned to use the random-effects model in the meta-analysis because of substantial clinical and methodological heterogeneity between studies, which by themselves could generate substantial statistical heterogeneity. When data from primary studies were not parametric (for example effects were reported as medians, quartiles, etc) or were without sufficient statistical information (for example standard deviations, number of patients, etc) we planned to insert them into an 'Appendix'. Additionally, each clinically relevant estimate effect was presented in a Summary of findings for the main comparison (Schünemann 2009).
Subgroup analysis and investigation of heterogeneity
We planned to stratify our analysis by the following independent variables that are expected to be associated with heterogeneity.
• By clinical condition (e.g., trauma, pre-existing neurological and lung diseases).
• Different timing of 'early' and 'late' tracheostomies.
• Type of tracheostomy, such as percutaneous or surgical tracheostomy.
We planned to only conduct these analyses if data were available either in the report or by contacting the main authors of the studies. In spite of the number of defined subgroup analyses, the eventual statistical heterogeneity observed across subgroups would not be assumed to be a true causal relationship between dependent and independent variables but only as generating a hypothesis to be tested in future trials.
Sensitivity analysis
If there were an adequate number of studies, we planned to perform a sensitivity analysis to explore the causes of heterogeneity and the robustness of the results. We planned to consider the following factors in the sensitivity analysis: quality of allocation concealment (adequate or unclear or inadequate); blinding (adequate or unclear or inadequate or not performed); analysis using both random-effects or fixed-effect models; intention-to-treat analysis and available case analysis (only for dichotomous data), and studies with different times of early and late tracheostomies from our inclusion criteria. We did not plan to include the results obtained from subgroup and sensitivity analyses as conclusions. We intended that they would be used for hypothesis generation to be tested in future adequately designed studies.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies; Characteristics of ongoing studies.
Results of the search
The search strategy retrieved 1433 citations across all electronic databases. We excluded duplicate references and thus retrieved 1219 unique citations. Of these citations, we excluded a further 1134, on the basis of title and abstract, because they were not specifically related to the 'timing of tracheostomy'. From the remaining 85 studies, we excluded a further 74 because of their study design. Thus, 11 studies had the potential to be included in the review (Figure 1 ). Of those 11 studies, we contacted the main authors of one study for further information about the comparison groups (Blot 2008) . This study was later excluded for the reasons outlined in the Characteristics of excluded studies. At the title and abstract stage of selection, the Kappa coefficients (Kc) to evaluate the concordances between the two observers (RA and BNG) were calculated in the databases where there was at least one discordance (Latour 1997). The concordance levels were considered excellent for three databases: Kc = 0.91 (CENTRAL), Kc = 0.85 (EMBASE), Kc = 0.94 (MEDLINE); and good for CINAHL (Kc = 0.63). For the other databases there was no discordance between the observers.
Included studies
We included four studies available in English language journals (Barquist 2006; Dunham 1984; Rumbak 2004; Terragni 2010) , with a total of 673 patients randomized to either early or late tracheostomy. The studies were diverse with respect to their inclusion criteria, methods of tracheostomy and outcomes measures (see Characteristics of included studies).
Excluded studies
We excluded six studies because they compared early tracheostomy with prolonged endotracheal intubation (Blot 2008; Bouderka 2004; El-Naggar 1976; Saffle 2002; Stauffer 1981; Sugerman 1997) . In one quasi-randomized study, the late tracheostomy was performed eight days after admission (< 10 days) breaching the selection criteria (> 10 days after intubation) for this review ( Rodriguez 1990) . For further details, see the Characteristics of excluded studies.
Risk of bias in included studies
We paid special attention to the description of randomization and allocation concealment, as the absence of adequate methodological aspects are associated with biased estimated effects (Schulz 1995) . A synthesis of the assessment of all of the items of methodological quality described below are presented in Figure 2 and Figure 3 . 
Allocation Randomization
Two studies (Barquist 2006; Terragni 2010) reported computergenerated randomization, which we considered to possess a low risk of bias. Neither study found significant differences between the comparison groups in terms of baseline characteristics. Dunham 1984 referred to randomization based upon the last digit of the patient's hospital number, a method which we deemed indicative of resulting in a high risk of bias (quasi-randomized study).
Rumbak 2004 did not explicitly report the method of randomization; thus the study was considered to reflect a moderate risk of bias.
Allocation concealment
Two studies (Barquist 2006; Rumbak 2004 ) utilized envelopes to conceal the allocation of participants. Terragni 2010 clearly reported a centralized process of randomization. These three studies were therefore considered to have a low risk of bias. However, Dunham 1984, a quasi-randomized study, was considered to pos-sess a high risk of bias associated with the allocation concealment.
Blinding
In three studies (Barquist 2006; Dunham 1984; Rumbak 2004) , no information was given as to whether the data collectors were independent from the researchers who designed the study, or were blinded to the allocations. These studies were thus considered to have a moderate risk of bias associated with potential knowledge about the allocated interventions (blinding). In contrast, Terragni 2010 clearly explained that a blinded clinician was responsible for looking at the clinical charts remotely and for evaluating nonobjective components of the Clinical Pulmonary Infection Score. Consequently, this study was deemed as possessing a low risk of bias associated with the blinding.
Incomplete outcome data
Two studies (Barquist 2006; Rumbak 2004) were considered to have a low risk of bias associated with incomplete outcome data, due to intention-to-treat (ITT) analysis and clear patient flow. Dunham 1984 was considered to possess a high risk of bias as, after randomization, only those patients who were intubated for at least seven days were included in the study. The authors did not indicate the percentages or number of patients not considered for analysis after randomization Terragni 2010 deserved special consideration because the authors reported ITT, but the numbers of patients from the randomization to the analysis of each outcome were not clearly reported for each one of the comparison groups. Therefore this study was considered to have a high risk of bias.
Selective reporting
Three studies were considered to have a low risk of bias based on the relevant outcomes considered for evaluation, and the absence of suspected selective outcome reporting (Barquist 2006; Rumbak 2004; Terragni 2010) . Dunham 1984 was deemed to be a study with high risk of systematic error due to the absence of clinically relevant outcomes (such as mortality rates).
Other potential sources of bias
Dunham 1984 evaluated 50% of the patients at four to six months after extubation. The remaining patients were interviewed 12 months after extubation but the exact number of patients per comparison group was not specified. No indication was given of the absence of substantial differences between the comparison groups at baseline (comparable groups). Three studies were lacking clear information about the time of follow-up for all of the outcomes (Barquist 2006; Rumbak 2004; Terragni 2010) . Thus, none of these studies were considered to be free of other biases. 
Effects of interventions
Duration of artificial ventilation
Terragni 2010 measured the median values of ventilator-free days at 28th day, which is considered a good outcome. The results showed statistically significant (P = 0.02) estimated effects favouring early tracheostomy (median 11 days, interquartile range 0 to 21 days) as compared to late tracheostomy (median 6 days, interquartile range 0 to 17 days) (Appendix 10). Such non-parametric data could not be reported as means and standard deviations (SD). Thus, they were not appropriate for insertion in a forest plot. Rumbak 2004 reported a lower mean of days on mechanical ventilation in the early tracheostomy group (7.4 days, SD = 4) when compared with the late group (17.4 days, SD = 5.3), with a statistically significant mean difference (MD) of -9.80 (95% CI -11.48 to -8.12, P < 0.001) ( 
Pneumonia
In the same way as for mortality, we tried to combine the pneumonia rates in a meta-analysis. We again found substantial heterogeneity between studies (Rumbak 2004; Terragni 2010) (I 2 = 0.73, P = 0.15). Such statistical heterogeneity was also justified because of the substantial clinical and methodological differences between studies. By consensus, we decided to present the data on pneumonia in a forest plot with isolated estimated effects from the studies, excluding a meta-analysis (Analysis 1.2). The percentage of events of pneumonia in the early tracheostomy group was 12.3% versus 21.9% in the late tracheostomy group. The effect estimate was even weaker (RR 0.69, 95% CI 0.45 to 1.05, P = 0.08) in Terragni 2010, which did not include patients with pneumonia at the study entry, than that observed in Rumbak 2004 (RR 0.20, 95% CI 0.06 to 0.66, P = 0.008).
Postoperative adverse events
The different studies included in this systematic review found no clinically or statistically relevant difference between early and late tracheostomies in the following postoperative adverse events: stoma inflammation; stoma infection; minor bleeding; major bleeding; pneumothorax; subcutaneous emphysema; tracheoesophageal fistula and cannula displacement or need for replacement (Terragni 2010); significant laryngotracheal pathology; respiratory sepsis; major complications; complications (Dunham 1984) ; tracheal stenosis, irrespective of the severity (in hospital); tracheal stenosis > 50 (10 weeks postintubation) (Rumbak 2004); and self extubation (Rumbak 2004). However, the following events occurred significantly more in the early tracheostomy group: tracheal stenosis with a severity score from 0 to 20 in hospital and 10 weeks after intubation; tracheal stenosis, irrespective of the severity, 10 weeks after intubation (Rumbak 2004) ( Table  1 , line 10).
Other potentially relevant outcomes not planned in the protocol of this systematic review
No significant difference was found between comparison groups related to the need for a long-term care facility; other outcomes looked at were: days spent on sedation and on high dose vasopressor infusion, intraoperative adverse events and events followed by death (Appendix 11).
Sensitivity analysis
Because of the relative paucity of adequate studies, a sensitivity analysis was not done.
D I S C U S S I O N Summary of main results
Available evidence from randomized controlled trials showed no significant change in mortality at any time of follow-up in the early tracheostomy group as compared to the late tracheostomy group. Three trials (Barquist 2006; Rumbak 2004; Terragni 2010) showed lower proportions of mortality at any time of follow-up in the early tracheostomy group as compared to late tracheostomy, but this is not strong evidence. Two observations from two different studies regarding the time spent on mechanical ventilation were also of importance. One study indicated that early tracheostomy reduces the time on mechanical ventilation by more than nine days (9.8 days) (Rumbak 2004) . The other study found more days 'free from the ventilator', measured at day 28 of follow-up (Terragni 2010), in the early tracheostomy group. This study excluded patients with chronic obstructive pulmonary disease, which is more likely to require longterm ventilation. Additionally, the same study (Terragni 2010) demonstrates that early tracheostomy is significantly associated with a higher rate of successful weaning. With respect to the secondary outcomes, the available evidence from only one study involving more than 400 patients (Terragni 2010) demonstrates that early tracheostomy is significantly associated with a higher rate of discharge from the ICU at day 28. Early tracheostomy again proved to be significantly superior to late tracheostomy in terms of the mean time spent in the ICU, but no differences were observed for ICU-free days at 28 days, the need for a long-term care facility or length of hospital stay (Terragni 2010).
There is no evidence to suggest that any one treatment is associated with lower probability of pneumonia, possibly because of the large heterogeneity between the studies (Rumbak 2004; Terragni 2010); Terragni 2010 in fact excluded patients with chronic obstructive pulmonary disease and pneumonia at study entry.
Overall completeness and applicability of evidence
There is not sufficient evidence to recommend either early or late tracheostomy in clinical practice since the findings of this systematic review did not demonstrate significant differences between the comparison groups measuring risk of mortality and pneumonia 
Quality of the evidence
Evidence in this review cannot be considered robust due to the low number of studies (Barquist 2006; Dunham 1984; Rumbak 2004; Terragni 2010 ) and the relatively low sample power for each of the relevant outcomes (599 patients at most for mortality). Although the estimated effects of studies with relevant outcomes (mortality and pneumonia) had the same direction, their intensities differed significantly, as demonstrated by heterogeneity tests. Such statistical heterogeneity probably resulted from the clinical and methodological diversity among the studies (for example, the date of realization, inclusion criteria, geographic region, and methods of tracheostomy). According to the Summary of findings for the main comparison the quality of the evidence was considered low for the outcomes of death and pneumonia, and moderate for successful weaning from mechanical ventilation.
Potential biases in the review process
A high sensitivity search strategy was used in this systematic review so as to avoid missing any randomized controlled trial that compared early versus late tracheotomy in critically ill patients. We prevented any language bias by not imposing language restrictions upon the search. 
Agreements and disagreements with other studies or reviews
The findings of our systematic review and the reviews by Dunham 2006 and Griffiths 2005 do not support either early or late tracheostomy for mortality. Scales 2008, in a large observational study involving more than 10,000 patients, showed that early tracheostomy was associated with significant advantages in terms of mortality over late tracheostomy for critically ill patients. Previous systematic reviews, as well as other observational studies and non-randomized controlled trials with lower methodological rigour, also showed a decreased amount of time spent on ventila- tory 
A U T H O R S ' C O N C L U S I O N S Implications for practice
The evidence in this Cochrane review is insufficient to recommend either early or late tracheostomy for critically ill patients. We have insufficient information about any subgroup or individual characteristic(s) potentially associated with the best indications for either early or late tracheostomy.
Implications for research
Additional high quality randomized controlled trials are necessary to evaluate possible differences between early and late tracheostomy for critically ill patients. Some trials have already begun, and we are awaiting their results for an updated version of this systematic review. Researchers would contribute significantly to improving the evidence by considering the following outcome measures: mortality rates up to 12 months of follow-up, time spent on mechanical ventilation and in the ICU, length of hospital stay, successful weaning, pneumonia and costs. All researchers interested in this research area should work together to unify the raw data collected in their studies in order to make more information available for inferences about more precise indications.
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C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Barquist 2006
Methods Study design: parallel randomized controlled trial with intention-to-treat analysis and sample size based in the following information: a total of 140 patients would be needed if the SD was nine ventilator days, the difference between means was three days and the power was set at 90% 
Outcomes
• Mortality rates (time of data collection was not explicitly referred by the authors)
• Mean ICU free days at 20 days:
• Mean Ventilation free at day 30 (with extubation performed after spontaneous breathing trial [CPAP at 5 cm water pressure with 5 cm water pressure support for 30 minutes] with predefined criteria for passing [pO2 greater than 55 mm Hg, respiratory rate less than 35 breaths/minute and no respiratory acidosis)]
• Mean ICU free at day 30 • Ventilator-associated pneumonia at any time point (CDC CRITERIA: Centers for Disease Control: elevated WBC, fevers, CXR infiltrate, and Broncho-Alveolar Lavage [BAL] culture with greater than 10,000 colony-forming units per millilitre [CFU/mL])
• Single superficial surgical site infection • Major complications related to the tracheostomy (including stomal infection, stomal haemorrhage, major vascular injury, pneumothorax, subglottic stenosis, and tracheo-oesophageal fistulae)
Notes
Four patients in the 'late' group had a surgical tracheostomy placed on days 17, 18, 19, and 21 to facilitate transfer to long-term care Method to predict prolonged artificial ventilation: Not explicitly reported Other bias High risk Although times of follow-up were explicitly announced for only three outcomes (mean ICU free days at 20 days, mean ventilation free at day 30, mean ICU free at day 30), the authors were not explicit to report the follow-up times for the other outcome data 
Risk of bias
Outcomes
• Significant laryngotracheal pathology (irrespective of type) that required surgery and/or prolonged tracheal intubation beyond that required for the patient's general condition
• Respiratory sepsis (tracheitis, pneumonia, lung abscess, and peristomal infection)
• Major complications (not explicitly defined by the authors)
• Complications (self-extubation, patient tolerance, respiratory hygiene, and aspiration)
• Proportion of patients intubated for until 21 days Notes Method to predict prolonged artificial ventilation: patients were randomized into an early or late tracheostomy group If at the end of 48 to 72 hours of translaryngeal intubation the attending surgeon felt that a patient needed at least 48 hours of additional tracheal intubation Gender: Not informed Incomplete outcome data (attrition bias) All outcomes
Risk of bias
High risk
Intention-to-treat analysis (ITT) was announced by the authors, but the exact method was not clearly reported. The numbers of patients from the randomization to the analysis of each outcomes were not coherent. The authors of this systematic review could not perform the most accepted ITT analysis performed by imputing the undesired outcome for all patients who dropped-out and/or for those who withdrawn from the planned protocol The addition of the number of patients who died at 28 days and one year (reported in the article) plus the number of withdrawals from protocol exceeds the number of randomized patients. Similarly, the addition of all explicitly reported deaths at the 28 days and at one year of follow-up plus the difference between the total of randomized participants minus the number of participants "who left the hospital alive" is incompatible with the total number of randomized participants The difference between the total of randomized patients minus the number of participants "who left the hospital alive" is incoherent with the number of death at 28 days Critically ill adults Adults with a disease or in a state in which death is possible or imminent
A D D I T I O N A L T A B L E S
Early tracheostomy
Although not precisely defined, it usually refers to a tracheostomy performed from two days to 10 days after intubation Late tracheostomy Although not precisely defined, it usually refers to a tracheostomy performed after 10 days of intubation Percutaneous tracheostomy Usually a tracheostomy based on: 1) needle-guide wire airway access followed by serial dilations with sequentially larger dilators; 2) guide wire dilating forceps; 3) mini tracheostomy only for emergency airway access or for aspiration of retained bronchopulmonary secretions
